SC II Acquisition Corp. - Rights (SCIIR)
Community market perspectives and discussion for SC II Acquisition Corp. - Rights (NASDAQ: SCIIR).
Community market perspectives and discussion for SC II Acquisition Corp. - Rights (NASDAQ: SCIIR).
On our desk, SCIIR is tracking a very negative 3-month sentiment profile. With the stock lingering around $0.18 and technical indicators reflecting high volatility with a 10.19% spread, the overall market tone is heavily bearish. Watching the 50-day simple moving average near $0.2115 gives us a clear ceiling for any dead-cat bounces while the broader sector stays flat.
From a risk management standpoint, the termination of the non-binding letter of intent on July 12, 2026, to acquire the payments technology firm completely alters the investment thesis for this blank check vehicle. Without an active target under LOI, rights holders face extreme event risk and compressed valuations heading into the back half of the year.
Looking at the institutional flows reported in recent SEC filings, the smart money is heading for the exits. Harraden completely exited its position above 5% by mid-May 2026, and Mizuho reported a reduced 3.0% stake holding 520,817 shares. When primary institutional sponsorship dwindles like this, retail participants are left holding an illiquid shell.
As a hedge fund portfolio manager reviewing the Q2 2026 disclosures, the mention of a trust-driven profit in the Form 10-Q filing provides some baseline asset backing, but it fails to compensate for the failed acquisition catalyst. The cancellation of deal plans leaves the rights with negligible fundamental catalysts outside of liquidation mechanics.
Quantitatively speaking, the long-term price predictions for SCIIR point downward, estimating further depreciation toward $0.1566 by the end of 2026 and cascading down toward $0.09469 by 2030. With a Fear and Greed index score sitting at 39 and only 30% green days over a 30-day window, momentum indicators offer no safe entry point.
Explore plasma cleansing, somatic organ swaps, and BCI.